Literature DB >> 19754306

Impaired interferon-gamma responses, increased interleukin-17 expression, and a tumor necrosis factor-alpha transcriptional program in invasive aspergillosis.

Darius P H Armstrong-James1, Suzy A Turnbull, Ian Teo, Jaroslav Stark, Nicola J Rogers, Thomas R F Rogers, Elaine Bignell, Ken Haynes.   

Abstract

BACKGROUND: Invasive aspergillosis (IA) is the most common cause of death associated with fungal infection in the developed world. Historically, susceptibility to IA has been associated with prolonged neutropenia; however, IA has now become a major problem in patients on calcineurin inhibitors and allogenic hematopoietic stem cell transplant patients following engraftment. These observations suggest complex cellular mechanisms govern immunity to IA.
METHODS: To characterize the key early events that govern outcome from infection with Aspergillus fumigatus, we performed a comparative immunochip microarray analysis of the pulmonary transcriptional response to IA between cyclophosphamide-treated mice and immunocompetent mice at 24 h after infection.
RESULTS: We demonstrate that death due to infection is associated with a failure to generate an incremental interferon-gamma response, increased levels of interleukin-5 and interleukin-17a transcript, coordinated expression of a network of tumor necrosis factor-alpha-related genes, and increased levels of tumor necrosis factor-alpha. In contrast, clearance of infection is associated with increased expression of a number genes encoding proteins involved in innate pathogen clearance, as well as apoptosis and control of inflammation.
CONCLUSION: This first organ-level immune response transcriptional analysis for IA has enabled us to gain new insights into the mechanisms that govern fungal immunity in the lung.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19754306     DOI: 10.1086/605931

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

1.  Coevolution of TH1, TH2, and TH17 responses during repeated pulmonary exposure to Aspergillus fumigatus conidia.

Authors:  Benjamin J Murdock; Andrew B Shreiner; Roderick A McDonald; John J Osterholzer; Eric S White; Galen B Toews; Gary B Huffnagle
Journal:  Infect Immun       Date:  2010-11-01       Impact factor: 3.441

Review 2.  Host immune defense against Aspergillus fumigatus: insight from experimental systemic (disseminated) infection.

Authors:  I Mirkov; S Stosic-Grujicic; M Kataranovski
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

3.  Embryonated eggs as an alternative infection model to investigate Aspergillus fumigatus virulence.

Authors:  Ilse D Jacobsen; Katharina Grosse; Silvia Slesiona; Bernhard Hube; Angela Berndt; Matthias Brock
Journal:  Infect Immun       Date:  2010-04-26       Impact factor: 3.441

4.  RNA-Seq Profile Reveals Th-1 and Th-17-Type of Immune Responses in Mice Infected Systemically with Aspergillus fumigatus.

Authors:  Jata Shankar; Gustavo C Cerqueira; Jennifer R Wortman; Karl V Clemons; David A Stevens
Journal:  Mycopathologia       Date:  2018-03-02       Impact factor: 2.574

5.  CD4+ T cells mediate the protective effect of the recombinant Asp f3-based anti-aspergillosis vaccine.

Authors:  Diana Diaz-Arevalo; Karine Bagramyan; Teresa B Hong; James I Ito; Markus Kalkum
Journal:  Infect Immun       Date:  2011-03-21       Impact factor: 3.441

Review 6.  Immunity to fungal infections.

Authors:  Luigina Romani
Journal:  Nat Rev Immunol       Date:  2011-03-11       Impact factor: 53.106

7.  Immunomodulation Therapy for Invasive Aspergillosis: Discussion on Myeloid Growth Factors, Recombinant Cytokines, and Antifungal Drug Immune Modulation.

Authors:  Amar Safdar
Journal:  Curr Fungal Infect Rep       Date:  2010-03

Review 8.  Clinical implications of interferon-γ genetic and epigenetic variants.

Authors:  Nicola L D Smith; David W Denning
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

9.  Nebulised amphotericin B-polymethacrylic acid nanoparticle prophylaxis prevents invasive aspergillosis.

Authors:  Khojasteh Shirkhani; Ian Teo; Darius Armstrong-James; Sunil Shaunak
Journal:  Nanomedicine       Date:  2015-03-16       Impact factor: 5.307

Review 10.  Aspergillus-associated airway disease, inflammation, and the innate immune response.

Authors:  Sanjay H Chotirmall; Mazen Al-Alawi; Bojana Mirkovic; Gillian Lavelle; P Mark Logan; Catherine M Greene; Noel G McElvaney
Journal:  Biomed Res Int       Date:  2013-07-21       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.